Thomas F. Gajewski, MD, PhD

Professor of Medicine

Thomas Gajewski, MD, PhD, investigates and develops new treatments for patients with melanoma. He has a special interest in the development of immunotherapies against this disease. Dr. Gajewski also leads development of immune-based therapies for other cancers, using new laboratory data on how the immune system is regulated to develop novel clinical trials.

Dr. Gajewski serves as an editor for Cancer Research and Journal for Immunotherapy of Cancer. In addition, he is immediate past president of the Society for Immunotherapy of Cancer and has served on the program committees for the American Society for Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR).

Practice Locations

The University of Chicago Medicine
5841 S. Maryland Avenue
Chicago, IL 60637

Center for Advanced Medicine
5758 S. Maryland Avenue
Chicago, IL 60637

Year Started Practice

1993

Board Certification

Medical Oncology

Medical School

University of Chicago

Internship, Residency and Fellowship

The University of Chicago Medicine

Memberships

American Association of Cancer Research
American Association of Immunologists
American Society of Clinical Oncology
Society for Immunotherapy of Cancer

Language Spoken

English

Email

tgajewsk@medicine.bsd.uchicago.edu

Office Phone

(773) 702-6149

Office Fax

(773) 702-3163

Office Postal Address

Thomas F. Gajewski, MD, PhD
The University of Chicago Medicine
5841 S. Maryland Avenue, MC 2115
Chicago, IL 60637

Physician Photo

Clinical Interests

Melanoma
New drug development
Immunotherapy

Request an appointment online
or call UCM Connect at
1-888-824-0200

Physicians, contact the
Referring Physician Access Line
at 1-877-DOM-2730

Selected Publications

View a partial list of Dr. Gajewski's publications through the National Library of Medicine's PubMed online database.